$383 Million is the total value of Ghost Tree Capital, LLC's 39 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IMMU | IMMUNOMEDICS INC | $15,368,000 | +34.6% | 800,000 | 0.0% | 4.02% | -3.1% | |
| VRTX | VERTEX PHARMACEUTICALS INC | $14,716,000 | +11.0% | 80,000 | 0.0% | 3.84% | -20.1% | |
| RTRX | RETROPHIN INC | $11,315,000 | 0.0% | 500,000 | 0.0% | 2.96% | -28.0% | |
| RCKT | ROCKET PHARMACEUTICALS INC | $10,524,000 | +18.4% | 600,000 | 0.0% | 2.75% | -14.8% | |
| VRAY | VIEWRAY INC | $5,543,000 | +21.7% | 750,000 | 0.0% | 1.45% | -12.3% | |
| ORTX | ORCHARD THERAPEUTICS PLCads | $5,364,000 | +13.7% | 300,000 | 0.0% | 1.40% | -18.2% | |
| BCRX | BIOCRYST PHARMACEUTICALS | $4,070,000 | +0.9% | 500,000 | 0.0% | 1.06% | -27.4% | |
| ARVN | ARVINAS INC | $2,583,000 | +14.9% | 175,000 | 0.0% | 0.68% | -17.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2020-04-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.